© Medical Review Institute of America LLC. All rights reserved.
MRIoA’s MyCareChoicesTM–Rx Plus provides a timely independent clinical review and 2nd opinion for rare or orphan drug therapy options that in many cases are very costly and may not be the best option for the patient. Patients and their prescribers receive answers from national experts in rare diseases and an assessment of the member’s condition, including diagnostic workup, management, and treatment plan.
MRIoA allows health plans, TPAs and PBMs to implement cost-saving solutions for the management of patients who are being prescribed high-cost medications while increasing member satisfaction and ensuring members have access to the right medications at the right time.